Investor Presentation January 2022

CooperSurgical Fertility portfolio well positioned for success Business Highlights Broadest medical device coverage of the entire IVF cycle(1) Pioneers in IVF genetic testing (state-of-the- art R&D lab) Recently closed Generate Life Science acquisition (12/17/21) Enables new strategic growth opportunities - egg & sperm donation, cryopreservation Increases product offerings, leverages sales force Cooper Companies 1. Fertility Industry Highlights Medical Devices for the IVF Cycle(1) $1.8B+ Global Market¹ 5-10% Annual Growth Fertility Workup Andrology IUI Growth Drivers: Increasing maternal age Greater access to treatment Culture Increased patient awareness/comfort Greater worldwide disposable income Up to 1 in 8 couples suffer from infertility worldwide Manufacturer sales of products and services excluding consultation and pharma Source: Management estimates and independent market research Fertilization Oocyte Retrieval I/H Embryo Biopsy & Testing Cryopreservation Transfer 16

View entire presentation